Acceleron Pharma Inc (XLRN) - Comprehensive Stock Analysis & Investment Research
Deep dive into Acceleron Pharma Inc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about Acceleron Pharma Inc, including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
For Acceleron Pharma Inc: Acceleron Pharma Inc operates in the Manufacturing sector, positioning it as a large-cap market leader.
Acceleron Pharma Inc (Stock Symbol: XLRN) is a leading company in the Manufacturing sector , specifically operating within the Biological Product (except Diagnostic) Manufacturing industry.
The organization employs approximately 312 professionals worldwide and operates under the strategic leadership of CEO Habib Dable.
The company has established itself as a major market leader with significant institutional backing.
Understanding Financial Performance
What these metrics mean: Key financial indicators showing Acceleron Pharma Inc's revenue scale, profitability, market value, and shareholder returns.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Acceleron Pharma Inc: With $113M in annual revenue and -226.0% net margin, the company demonstrates developing profitability.
Annual Revenue: $113 million generating a -226.0% net profit margin .
Market Capitalization: $10904 million - Classified as a large-cap stock with institutional-grade stability.
Return on Equity (ROE): -31.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for Acceleron Pharma Inc stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.
For Acceleron Pharma Inc: Unlock premium access to view detailed AI predictions and price targets.
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Acceleron Pharma Inc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Understanding Market Position
What this analysis covers: Acceleron Pharma Inc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
For Acceleron Pharma Inc: Market positioning analysis based on available financial and operational metrics.
Acceleron Pharma Inc strategically competes in the highly dynamic Biological Product (except Diagnostic) Manufacturing marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .
The company maintains a healthy 100.0% gross margin, indicating strong pricing power and operational efficiency.